Archives
|
Entry
|
Blogger
|
Date
|
Location
|
|
Vertex and Ironwood Drugs Fare Well in Clinical Trials, Pulmatrix Breathes in $30.2M, IRobot Launches Healthcare Unit, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
11/04/09 |
Boston
|
|
Alkermes Anti-Addiction Drug Fares Well in Clinical Trials, Amgen Takes Aim at Drug-Development Success Rate, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
10/14/09 |
Boston
|
|
Joule Debuts Biofuel Technology, Genzyme Cleans House, Avila Banks $30M, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
07/29/09 |
Boston
|
|
Histogen Reports Hair-Raising Study Results
|
Denise Gellene |
07/27/09 |
San Diego
|
|
Biogen Idec Buys MS Drug Rights, Immuneering Models Cancer Drug Responses, Hologic Wins Contraceptive Device Approval, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
07/08/09 |
Boston
|
|
Icahn Bags Two Biogen Board Seats, Pharma Giants Add $40M to Aileron Coffers, Pulmatrix Proceeds With Tests of Flu-Blocking Aerosol, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
06/10/09 |
Boston
|
|
Clinical Data Touts Antidepressant Trial Data
|
Roxanne Palmer |
06/02/09 |
Boston
|
|
Genentech Veteran Takes Agios’ Helm, E8 and MIT Take on Navigenics, Genzyme’s Mipomersen Takes Next Step, Alnylam Takes Advantage of Tekmira Technology, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
05/28/09 |
Boston
|
|
Infinity Halts Trial of Lead Cancer Drug, Tysabri Sales Short of Projections, Myomo Slashes Staff, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
04/22/09 |
Boston
|
|
Dendreon Immune Booster for Prostate Cancer Helps Men Live Longer; Shares Boom
|
Luke Timmerman |
04/14/09 |
Seattle
|
|
Funding Pool Deep for Still River, Cuts in the Offing for Epix and Synta, FDA Approvals Granted for Hologic, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
03/18/09 |
Boston
|
|
Vertex Puts up $375M for ViroChem, Nuance Finally Nabs Zi, Proteon Procures $38M, & More Boston-Area Deals News
|
Rebecca Zacks |
03/06/09 |
Boston
|
|
Synta Melanoma Drug Trial Halted, Drug Regulators Hand Genzyme Mixed Bag, Ariad and ImmunoGen Reach Milestones, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
03/04/09 |
Boston
|
|
Genzyme and Boston Scientific Get Good News From the FDA; Acusphere and Targanta Not So Much; TransMedics Pulls IPO Plug; & More Boston-Area Life Sciences News
|
Rebecca Zacks |
12/17/08 |
Boston
|
|
GSK Pays Synta $15M
|
Rebecca Zacks |
12/12/08 |
Boston
|
|
Resolvyx Closes in on Clinical Trials, Radius Health Reels in $15M, Luke Zeros in on Public Biotechs’ Bottom Line, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
11/26/08 |
Boston
|
|
RXi Tackles RNAi Delivery, Pfizer Launches A Two-Cambridge Stem Cell Effort, Archemix Plows An Alternative Path to the Public Market, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
11/20/08 |
Boston
|
|
Adventrx Cuts One-Fourth of Staff, CEO Resigns
|
Lauren Gravitz |
10/20/08 |
San Diego
|
|
No Appeal for Boston Scientific, No Luck for CombinatoRx Drug, No Complaints From Harvard, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
10/08/08 |
Boston
|
|
Indevus Puts New Acromegaly Treatment Head-to-Head with Novartis Treatment in Phase 3 Trial
|
Ryan McBride |
09/30/08 |
Boston
|
|
Radius Health is Betting on a Better Treatment for Osteoporosis
|
Erik Mellgren |
04/17/08 |
Boston
|
|
Vertex on the Rise, Sirtris on TV, an IPO (Finally) on the Table, and More Life Sciences News
|
Rebecca Zacks |
04/02/08 |
Boston
|
|
Vertex Climbs on Encouraging Early Results From Cystic Fibrosis Drug Trial
|
Rebecca Zacks |
03/27/08 |
Boston
|
|
Repligen Launches Trial of Imaging Agent
|
Rebecca Zacks |
03/26/08 |
Boston
|
|
Cancer Patient Can Use Newton Firm’s Drug, FDA Says
|
Rebecca Zacks |
03/24/08 |
Boston
|
|
GTC Biotherapeutics, Racing Against Time to Prove the Worth of “Pharming”
|
David Stipp |
02/11/08 |
Boston
|
|
GTC Biotherapeutics Drug Passes Clinical Milestone, Helping Blaze the Trail for U.S. “Pharming”
|
David Stipp |
02/05/08 |
Boston
|
|
For Logical Therapeutics It’s a New City and a New Approach to Anti-Inflammatory Drugs; For the CEO, It’s a Whole New Career
|
Rebecca Zacks |
12/13/07 |
Boston
|
|
Millennium Presents Positive Data for Velcade
|
Malorye Allison |
12/11/07 |
Boston
|
|
GTC Drug Gets Orphan Status
|
Rebecca Zacks |
12/10/07 |
Boston
|
|
Page 1 of
2 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2009, Xconomy, Inc.
XCONOMY is a registered service mark of Xconomy, Inc.
All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
